[
    "ep=\"0\" cols=\"3\"><colspec colname=\"offset\" colwidth=\"35pt\" align=\"left\"/><colspec colname=\"1\" colwidth=\"49pt\" align=\"left\"/><colspec colname=\"2\" colwidth=\"133pt\" align=\"center\"/><tbody valign=\"top\"><row><entry/><entry>Compound</entry><entry>IC<sub>50 </sub>\u00b1 SD (\u03bcM)</entry></row><row><entry/><entry namest=\"offset\" nameend=\"2\" align=\"center\" rowsep=\"1\"/></row></tbody></tgroup><tgroup align=\"left\" colsep=\"0\" rowsep=\"0\" cols=\"3\"><colspec colname=\"offset\" colwidth=\"35pt\" align=\"left\"/><colspec colname=\"1\" colwidth=\"49pt\" align=\"left\"/><colspec colname=\"2\" colwidth=\"133pt\" align=\"char\" char=\".\"/><tbody valign=\"top\"><row><entry/><entry>\u2014</entry><entry/></row><row><entry/><entry>1 (RC1315)</entry><entry>&lt;5</entry></row><row><entry/><entry>2 (RC1375)</entry><entry>&lt;5</entry></row><row><entry/><entry>3 (RC1268)</entry><entry>\u22645</entry></row><row><entry/><entry>4 (RC1363)</entry><entry>\u226410</entry></row><row><entry/><entry>5 (RC1338)</entry><entry>&lt;5</entry></row><row><entry/><entry>6 (AB514)</entry><entry>&lt;0.1</entry></row><row><entry/><entry>8 (MIR002)</entry><entry>&lt;0.5</entry></row><row><entry/><entry namest=\"offset\" nameend=\"2\" align=\"center\" rowsep=\"1\"/></row></tbody></tgroup></table></tables></p><heading id=\"h-0101\">Example 21</heading><p id=\"p-0211\" num=\"0251\">Tumor cells were exposed for 24 h to new atypical retinoids (AR) and the anti-proliferative activity assessed upon 48 h recovery in drug-free medium with the SRB assay. RI=Resistance Index (ratio between the IC50 values of resistant and sensitive cells). Results are reported in the following table 3.</p><p id=\"p-0212\" num=\"0252\"><tables id=\"TABLE-US-00004\" num=\"00004\"><table frame=\"none\" colsep=\"0\" rowsep=\"0\" pgwide=\"1\"><tgroup align=\"left\" colsep=\"0\" rowsep=\"0\" cols=\"1\"><colspec colname=\"1\" colwidth=\"273pt\" align=\"center\"/><thead><row><entry namest=\"1\" nameend=\"1\" rowsep=\"1\">TABLE 3</entry></row></thead><tbody valign=\"top\"><row><entry namest=\"1\" nameend=\"1\" align=\"center\" rowsep=\"1\"/></row><row><entry>Human Adarotene-resistant NCI-H460 (R9A) NSCLC, MM487-Luc</entry></row><row><entry>mesothelioma, parent A2780 and A2780-Dx multidrug-resistant ovarian cancer</entry></row><row><entry>cell lines, U87MG glioblastoma cells exposed to new atypical retinoids.</entry></row></tbody></tgroup><tgroup align=\"left\" colsep=\"0\" rowsep=\"0\" cols=\"2\"><colspec colname=\"1\" colwidth=\"63pt\" align=\"left\"/><colspec colname=\"2\" colwidth=\"210pt\" align=\"center\"/><tbody valign=\"top\"><row><entry/><entry>IC<sub>50 </sub>\u00b1 SD (\u03bcM)</entry></row></tbody></tgroup><tgroup align=\"left\" colsep=\"0\" rowsep=\"0\" cols=\"7\"><colspec colname=\"1\" colwidth=\"63pt\" align=\"left\"/><colspec colname=\"2\" colwidth=\"35pt\" align=\"center\"/><colspec colname=\"3\" colwidth=\"42pt\" align=\"center\"/><colspec colname=\"4\" colwidth=\"35pt\" align=\"center\"/><colspec colname=\"5\" colwidth=\"35pt\" align=\"center\"/><colspec colname=\"6\" colwidth=\"42pt\" align=\"center\"/><colspec colname=\"7\" colwidth=\"21pt\" align=\"center\"/><tbody valign=\"top\"><row><entry>Compo",
    "1\u2032-biphenyl]-4-yl)acrylic acid</heading><p id=\"p-0238\" num=\"0278\">3-{3\u2032-Adamantan-1-yl-4\u2032-[(tetrahydropyran-2-yloxycarbamoyl)-methoxy]-biphenyl-4-yl}-acrylic acid tert-butyl ester (250 mg, 0.425 mmol) was added portionwise to 3.5 ml of TFA at 0\u00b0 C. under nitrogen and the mixture was stirred at 0\u00b0 C. for 1h. The pink suspension was filtered, the solid was washed with water until neutral pH to give 175 mg (92%) of desired compound as white solid, m.p. 265\u00b0 C., Rf (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 18:2) 0.49. 1H-NMR (300 MHz, CDCl<sub>3</sub>+TFA) \u03b4: 7.91 (1H, d, J=16.0 Hz), 7.67-7.59 (4H, m), 7.55 (1H, d, J=2.22 Hz), 7.47 (1H, dd, J=8.30 Hz, J=2.22 Hz), 6.90 (1H, d, J=8.30 Hz), 6.49 (1H, d, J=16.0 Hz), 4.78 (2H, s), 2.20-2.10 (9H, m), 1.91-1.72 (6H, m). 13C-NMR (300 MHz, DMSO-d6) \u03b4: 168.1, 164.8, 157.7, 144.0, 142.5, 138.8, 133.0, 132.3, 129.2 (\u00d72C), 127.1 (\u00d72C), 125.6, 125.2, 119.1, 114.0, 66.4, (5C missing due to the overlap with signal solvent), 37.1, 36.9, 28.9 (\u00d73C).</p><heading id=\"h-0120\">Synthesis of (E)-3-(3\u2032-adamantan-1-yl)-4\u2032-((1-(hydroxyamino)-1-oxopropan-2-yl)oxy)-[1,1\u2032-biphenyl]-4-yl)acrylic acid (GEM144)</heading><heading id=\"h-0121\">(E)-3-(3\u2032-adamantan-1-yl)-4\u2032-((1-ethoxy-1-oxopropan-2-yl)oxy)-[1,1\u2032-biphenyl]-4-yl)acrylic acid tert-butyl ester</heading><p id=\"p-0239\" num=\"0279\">To a solution of 3-(3\u2032-adamantan-1-yl-4\u2032-hydroxy-biphenyl-4-yl)-acrylic acid tert-butyl ester (500 mg, 1.16 mmol) in dry acetone (7 mL), K<sub>2</sub>CO<sub>3 </sub>(641 mg, 4.64 mmol), KI (13 mg, 0.08 mmol) and 2-bromopropionic acid ethyl ester (180 \u03bcL, 1.39 mmol), were added under nitrogen. The mixture was heated 5 h to reflux. K<sub>2</sub>CO<sub>3 </sub>was filtered, and the solvent removed in vacuo. The crude was triturated with hexane:diethyl ether 5:1, the precipitate was filtered to give 340 mg of title compound. Yield: 55%. m.p. 88\u00b0 C., Rf (petroleum ether/ethyl acetate 92.5:7.5) 0.30.</p><p id=\"p-0240\" num=\"0280\">1H-NMR (300 MHz, CDCl3) \u03b4: 7.61 (1H, d, J=15.7 Hz), 7.57-7.52 (4H, m), 7.49 (1H, d, J=2.3 Hz), 7.35 (1H, dd, J=2.3, 8.4 Hz), 6.71 (1H, d, J=8.4 Hz), 6.38 (1H, d, J=15.7 Hz), 4.88 (1H, q, J=6.6 Hz), 4.22 (2H, q, J=7.1 Hz), 2.31-2.14 (6H, m), 2.13-2.04 (3H, m), 1.84-1.74 (6H, m), 1.71 (3H, d, J=6.6 Hz), 1.54 (9H, s), 1.25 (3H, t, J=7.1 Hz).</p><heading id=\"h-0122\">(E)-3-(3\u2032-adamantan-1-yl)-4\u2032-(1-carboxyethoxy)-[1,1\u2032-biphenyl]-4-yl)acrylic acid tert-butyl ester</heading><p id=\"p-0241\" num=\"0281\">To a solution of (E)-3-(3\u2032-adamantan-1-yl)-4\u2032-((1-ethoxy-1-oxopropan-2-yl)oxy)-[1,1\u2032-biphenyl]-4-yl)acrylic acid tert-butyl ester (500 mg, 0.94 mmol) in aq. 50% THF (30 mL), LiOH\u00b7H<sub>2</sub>O (198 mg, 4.71 mmol) was added. The solution was stirred overnight at rt. The solvent was evaporated, the crude was diluted in 1N KHSO<sub>4 </sub>and extracted with EtOAc. The combined organic extracts were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4 </sub>and concentrated in vacuo, to give 462 mg (98%) of title compound (white solid), m.p. 2",
    "h the MTT assay. HDAC=Histone Deacetylase. POLA1=DNA Polymerase Alpha 1.</p><heading id=\"h-0133\">Example 25</heading><p id=\"h-0134\" num=\"0000\">Synthesis of GEM144 and BIO 146</p><p id=\"p-0261\" num=\"0301\"><chemistry id=\"CHEM-US-00034\" num=\"00034\"><img id=\"EMI-C00034\" path=\"US11819484-20231121-C00034.TIF\" file=\"https://surechembl.org/api/assets/attachment/1182870596/US/20231121/B2/000011/81/94/84/US11819484-20231121-C00034.TIF\"/><attachments><attachment idref=\"CHEM-US-00034\" attachment-type=\"cdx\" file=\"US11819484-20231121-C00034.CDX\"/><attachment idref=\"CHEM-US-00034\" attachment-type=\"mol\" file=\"US11819484-20231121-C00034.MOL\"/></attachments></chemistry><br/>\nSynthesis of GEM 144\n</p><p id=\"p-0262\" num=\"0302\"><chemistry id=\"CHEM-US-00035\" num=\"00035\"><img id=\"EMI-C00035\" path=\"US11819484-20231121-C00035.TIF\" file=\"https://surechembl.org/api/assets/attachment/1182870657/US/20231121/B2/000011/81/94/84/US11819484-20231121-C00035.TIF\"/><attachments><attachment idref=\"CHEM-US-00035\" attachment-type=\"cdx\" file=\"US11819484-20231121-C00035.CDX\"/><attachment idref=\"CHEM-US-00035\" attachment-type=\"mol\" file=\"US11819484-20231121-C00035.MOL\"/></attachments></chemistry></p><heading id=\"h-0135\">3-[3\u2032-Adamantan-1-yl-4\u2032-(1-ethoxycarbonylethoxy)-biphenyl-4-yl]-acrylic acid tert-butyl ester (BIO114)</heading><p id=\"p-0263\" num=\"0303\">To a solution of 3-(3\u2032-adamantan-1-yl-4\u2032-hydroxy-biphenyl-4-yl)-acrylic acid tert-butyl ester (500 mg, 1.16 mmol) in dry acetone (7 mL), K2CO3 (641 mg, 4.64 mmol), KI (13 mg, 0.08 mmol) and 2-bromo-propionic acid ethyl ester (180 \u03bcL, 1.39 mmol), were added under nitrogen. The mixture was heated 5 h to reflux. K2CO3 was filtered, and the solvent removed in vacuo. The crude was triturated with hexane:diethyl ether 5:1, the precipitate was filtered to give 340 mg of the title compound. Yield: 55%. m.p. 88\u00b0 C., 1H-NMR (300 MHz, CDCl3): 7.61 (1H, d, J=15.7 Hz), 7.57-7.52 (4H, m), 7.49 (1H, d, J=2.3 Hz), 7.35 (1H, dd, J=2.3, 8.4 Hz), 6.71 (1H, d, J=8.4 Hz), 6.38 (1H, d, J=15.7 Hz), 4.88 (1H, q, J=6.6 Hz), 4.22 (2H, q, J=7.1 Hz), 2.31-2.14 (6H, m), 2.13-2.04 (3H, m), 1.84-1.74 (6H, m), 1.71 (3H, d, J=6.6 Hz), 1.54 (9H, s), 1.25 (3H, t, J=7.1 Hz).</p><p id=\"p-0264\" num=\"0304\">3-[3\u2032-Adamantan-1-yl-4\u2032-(1-carboxy-ethoxy)-biphenyl-4-yl]-acrylic acid tert-butyl ester (BIO117). To a solution of BIO114 (500 mg, 0.94 mmol) in aq. 50% THF (30 mL), LiOH\u00b7H2O (198 mg, 4.71 mmol) was added. The solution was stirred overnight at rt. The solvent was evaporated, the crude was diluted in 1N KHSO4 and extracted with EtOAc. The combined organic extracts were washed with brine, dried over anhydrous Na2SO4 and concentrated in vacuo, to give 462 mg (98%) of the title compound (white solid), m.p. 206\u00b0 C. 1H-NMR (300 MHz, DMSO-d6): 7.76-7.60 (m, 4H), 7.56 (d, 1H, J=15.9 Hz), 7.47 (dd, 1H, J=2.0, 8.4 Hz), 7.43 (d, 1H, J=2.0 Hz), 6.80 (d, 1H, J=8.4 Hz), 6.51 (d, 1H, J=15.9 Hz), 4.91 (q, 1H, J=6.5 Hz), 2.24-2.00 (m, 9H), 1.79-1.66 (m, 6H), 1.57 (d, 3H, J=6.5 Hz), 1.47 (9"
]